Streamlining Access to Vital Medications

The Egyptian Drug Authority (EDA) is implementing a multi-phased plan to improve the distribution and accessibility of controlled medications, including narcotics and drugs affecting psychological well-being, across the country. This initiative aims to meet patient needs while ensuring stringent regulatory oversight.

Expanding Pharmacy Network for Strategic Drug distribution

Dr. Yassin Rajaei, Assistant Chairman of the EDA, emphasized the commitment to supporting the health sector nationwide, aligning with the government’s directives to bolster health services. A key component of this strategy involves expanding the network of pharmacies authorized to dispense these medications. The EDA is working in close collaboration with the Egyptian pharmaceutical Trading Company to monitor the supply chain, ensuring adequate stock levels and secure distribution channels.

Phased Implementation for Nationwide Coverage

The expansion plan, initiated in October 2024, is being rolled out in three distinct phases:

• phase 1: Completed with the progress of the Emiri Ambulance Pharmacy in Cairo and the Giza Ambulance Pharmacy.
• phase 2: Launched in February 2025, adding nine pharmacies, including locations in Mansoura, Assiut, Tanta, Sohag, Aswan, Alexandria, Port Said, Kafr El Sheikh, and Menoufia.
• Phase 3: Currently underway, this phase will incorporate an additional 14 pharmacies across various governorates, expected to be completed within a month of Phase 2’s conclusion.

Upon completion of all phases, the network will encompass approximately 27 pharmacies strategically located throughout Egypt.

Enhanced Monitoring and Security Measures

Beyond expanding the pharmacy network, the EDA is implementing robust measures to prevent misuse and diversion of controlled substances. These measures include:

• Establishing an electronic link between pharmacies to track prescriptions and prevent duplicate dispensing of narcotics.
• equipping pharmacies with secure storage facilities specifically designed for controlled medications.
• Implementing comprehensive documentation and record-keeping systems in compliance with existing laws and regulations.

Prescription Protocols and Safeguards

Stringent protocols govern the prescribing and dispensing of controlled medications. Key aspects of these protocols include:

• Prescriptions must be written on official forms with serial numbers and the seal of the General Governance for Markets Control.
• Doctors receive monthly prescription books, with fees collected as per the Anti-Narcotics Law No. 182 of 1960.
• Prescriptions must be filled within five days of issuance and cannot be reused.
• Pharmacists must retain the original prescription, recording the date of dispensing and the prescription’s registration number.
• Patients may request a copy of the prescription for their records.

digital Transformation: The “Duanna” Project

In December 2024, the EDA launched the “Duanna” project, a digital tracking system for narcotic drugs and medications affecting psychological well-being. This initiative is part of the EDA’s broader efforts to enhance its digital infrastructure and leverage technology to improve integration between various sectors of the Egyptian state, ultimately benefiting the health of Egyptian citizens.

Ensuring Availability and Combating Scarcity

These initiatives underscore the Egyptian Pharmaceutical Authority’s dedication to organizing the distribution and availability of essential medications, particularly controlled substances. By expanding access points and implementing stringent monitoring systems, the EDA aims to ensure that patients receive the medications they need while minimizing the risk of misuse and diversion.This comprehensive approach reflects a commitment to both public health and regulatory oversight in the pharmaceutical sector.